Per the earlier question, "Will the FDA advise a pharmaceutical company in advance if one of their products is to be be included in a quarterly AERS report?" -- the answer is "yes."
According to my source inside the agency, "For all our communications we endeavored to communicate 24-48 hours in advance."
As far as today's inaugural report, sponsors were notified yesterday.
Question: why not sooner?
According to my source inside the agency, "For all our communications we endeavored to communicate 24-48 hours in advance."
As far as today's inaugural report, sponsors were notified yesterday.
Question: why not sooner?
